Sonoma Pharmaceuticals's total assets for Q3 2025 were $13.67M, a decrease of -0.12% from the previous quarter. SNOA total liabilities were $8.80M for the fiscal quarter, a 5.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.